HOME >> BIOLOGY >> NEWS
Popular Science outlines need for long-term studies and more regulation in A.R.T.

America Online to Carry Article Exclusively and Will Host Online Chat on Tuesday, February 11 at 8pm EST

New York, NY, February 6, 2003 -- In an article in its March issue (on newsstands February 11), Popular Science magazine describes the need for long-term studies and more regulation in assisted reproductive technology (ART). The article "Sallie has 2 Mommies & 1 Daddy," explores the science behind the risks of ART and the problems with the U.S. regulatory system that have allowed untested technologies to be used on patients for decades without oversight.

One in 11 couples in the United States is infertile. Desperation to have a child is widespread. Each year, thousands of these couples expose themselves and their future children to dangerous fertility treatments that were rushed from petri dishes to patients without regulation or human trials. About a million children have been born using assisted reproductive technology-otherwise known as ART-which has become so advanced, couples using it are statistically more likely to conceive a child than those relying on the old-fashioned natural approach.

The recent claim that a fringe group had cloned a human caused yet another wave of protests from scientists and politicians over reproductive cloning. It'll cause birth defects, they said, it'll create children with unimaginable problems. But with the spotlight on cloning, Americans missed one important point: For decades, fertility clinics have been doing precisely what scares experts about cloning. By using unregulated technologies on patients, they're creating children through experimental procedures with well-documented and potentially widespread risks. PopSci magazine's article examines and discusses the need for regulation and increased research into fertility methods.

The complete story can be found exclusively on AOL in the Health Channel (Keyword: Health Poll) beginning on February 6. Beginning on Monday, Feb
'"/>

Contact: Sara Delekta
sara.delekta@time4.com
917-868-4502
Popular Science
6-Feb-2003


Page: 1 2

Related biology news :

1. Popular Science announces Third Annual Brilliant 10
2. Popular Science announces second annual Brilliant 10: the countrys top young scientists
3. Popularizing precision agriculture
4. Popular weed killer feminizes native leopard frogs across Midwest
5. Popular weed killer disrupts frogs sexual development
6. Popular weed killer demasculinizes frogs, disrupts their sexual development
7. Popular pain analgesics found to affect central nervous system: Study identifies both peripheral and CNS mechanisms of action of NSAID use
8. Popular Diet Supplement May Be A Cancer Risk
9. Emu Meat Not A Popular Choice Among Consumers, Study Shows
10. New Studies Shed Light On Facial Features Of Popular Dinosaurs
11. Popular Cure-All Tea Can Cause Toxic Reactions

Post Your Comments:
(Date:10/17/2014)... . To date, ... overdoses, doctors are often limited to supportive therapy such as ... combination of drugs involved. So what can be done if ... ETH professor Jean-Christophe Leroux from the Institute of Pharmaceutical Sciences ... question. "The task was to develop an agent that could ...
(Date:10/16/2014)... efficiently, they are anything but sustainable: environmental damage ... is becoming increasingly evident. Despite their disadvantages, however, ... regarded as the sole possibility of achieving higher ... Bernhard Schmid, an ecology professor at the University ... agriculture and forestry. After all, a new study ...
(Date:10/15/2014)... As our ability to assess the pandemic risk from ... developments, we must not allow ourselves to become complacent ... an international consortium of scientists. , Influenza pandemics arise ... have yet to develop widespread immunity – spreads in ... in the past 100 years, the worst of which ...
Breaking Biology News(10 mins):Emergency aid for overdoses 2Emergency aid for overdoses 3Plant communities produce greater yield than monocultures 2Plant communities produce greater yield than monocultures 3Scientists 'must not become complacent' when assessing pandemic threat from flu viruses 2
(Date:10/22/2014)... Involution Studios , a healthcare software ... infographic, Understanding Ebola . The goal of ... to follow informative tool for anyone wanting to know ... prevention. , "As the news has spread in all ... represents not only a healthcare crisis with global impact, ...
(Date:10/22/2014)... According to new market research report ... Integration, Deployment & Support), by Service Model (SaaS, ... Others (Hybrid & Community)) - Global Forecast to ... Cloud Professional Services Market into various sub-segments with ... also identifies the drivers and restraints for this ...
(Date:10/22/2014)... SAN DIEGO and HONG KONG ... an innovative rare disease therapeutics enterprise, announced today that ... joined the company as vice president, research. Dr. McKew ... research, including key leadership positions at the National Institutes ... to its acquisition by Wyeth). Dr. McKew will lead aTyr,s ...
(Date:10/20/2014)... , Oct. 20, 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" ... which brings Q3 orders to $5.8 million and provides a good ... in North America and one in the ... bid new projects at record levels," said Peter Bruijns , ... at the end of Q3 than they have been for any ...
Breaking Biology Technology:Involution Studios' Ebola Infographic Provides Key Disease Information and Statistics at a Glance 2Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 2Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 3Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 4Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 5aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3
Cached News: